available for iOS, Android & web
April 18, 2012
Generic drugmakers, especially Sun Pharmaceutical Industries, are celebrating a landmark ruling by the US Supreme Court which has ruled in favour of the Indian drugmaker in its long-running patent battle with Novo Nordisk over the latter's diabetes drug Prandin
Making patients smile
Patients’ wellbeing can be just as important as
International Clinical Researcher of the Year 2016
Book your tickets today!
PharmaTimes 2015 Copyright | RSS Feed Subscriptions